Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Allium cepa bulb extract is a complex mixture obtained from the bulb of the onion plant (Allium cepa), containing a wide variety of bioactive phytochemicals such as flavonoids (notably quercetin and its glycosides), anthocyanins, organosulfur compounds (including alk(en)yl cysteine sulfoxides and their derivatives), saponins, pigments, and organic acids[1][2][3][4]. This extract demonstrates a variety of biological activities in vitro and in animal studies, including antioxidant, anti-inflammatory, cytoprotective, wound healing, and anti-cancer properties, mainly attributed to its high phenolic and organosulfur content[1][2][3][4]. However, "Allium cepa bulb extract" does not refer to a specific molecular target, but instead to a multi-component botanical preparation whose composition can vary according to origin and extraction method, making it unsuitable as a standardized therapeutic target. The major flavonoids found include quercetin glycosides and kaempferol; organosulfur compounds are responsible for characteristic smell and many bioactivities[1][2][3]. Reported biological effects are observed in cell and animal models, but its multi-component nature prevents assignment of standardized drug–target interactions[1][2][3]. In scientific research databases and pharmacological references, "Allium cepa bulb extract" would never be cataloged as a target in the sense of molecular pharmacology—it is more accurately described as a natural product or extract. In summary, "Allium cepa bulb extract" is not a target, but a complex mixture with diverse biological activity; its use as a molecular target in structured drug discovery is scientifically incorrect[1][2][3][4].
Scavenging of free radicals (antioxidant), Induction of DNA protection, Modulation of inflammatory pathways, Inhibition of cell proliferation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Allium cepa bulb extract.